Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection

James A. Harker, Debbie C P Lee, Yuko Yamaguchi, Belinda Wang, Alexander Bukreyev, Peter L. Collins, John S. Tregoning, Peter J M Openshaw

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Respiratory syncytial virus (RSV) is the main cause of bronchiolitis, the major cause of hospitalization of infants. An ideal RSV vaccine would be effective for neonates, but the immune responses of infants differ markedly from those of adults, often showing a bias toward T-helper 2 (Th2) responses and reduced gamma interferon (IFN-γ) production. We previously developed recombinant RSV vectors expressing IFN-γ and interleukin-4 (IL-4) that allow us to explore the role of these key Th1 and Th2 cytokines during infection. The aim of the current study was to explore whether an immunomodulation of infant responses could enhance protection. The expression of IFN-γ by a recombinant RSV vector (RSV/IFN-γ) attenuated primary viral replication in newborn mice without affecting the development of specific antibody or T-cell responses. Upon challenge, RSV/IFN-γ mice were protected from the exacerbated disease observed for mice primed with wild-type RSV; however, antiviral immunity was not enhanced. Conversely, the expression of IL-4 by recombinant RSV did not affect virus replication in neonates but greatly enhanced Th2 immune responses upon challenge without affecting weight loss. These studies demonstrate that it is possible to manipulate infant immune responses by using cytokine-expressing recombinant viruses and that neonatal deficiency in IFN-γ responses may lead to enhanced disease during secondary infection.

Original languageEnglish (US)
Pages (from-to)5294-5302
Number of pages9
JournalJournal of Virology
Volume84
Issue number10
DOIs
StatePublished - May 2010
Externally publishedYes

Fingerprint

Respiratory Syncytial Viruses
cytokines
lungs
immune response
Cytokines
Viruses
Interferons
Lung
viruses
interferons
Infection
infection
Interleukin-4
neonates
interleukin-4
virus replication
Respiratory Syncytial Virus Vaccines
Newborn Infant
mice
Bronchiolitis

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Harker, J. A., Lee, D. C. P., Yamaguchi, Y., Wang, B., Bukreyev, A., Collins, P. L., ... Openshaw, P. J. M. (2010). Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection. Journal of Virology, 84(10), 5294-5302. https://doi.org/10.1128/JVI.02503-09

Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection. / Harker, James A.; Lee, Debbie C P; Yamaguchi, Yuko; Wang, Belinda; Bukreyev, Alexander; Collins, Peter L.; Tregoning, John S.; Openshaw, Peter J M.

In: Journal of Virology, Vol. 84, No. 10, 05.2010, p. 5294-5302.

Research output: Contribution to journalArticle

Harker, JA, Lee, DCP, Yamaguchi, Y, Wang, B, Bukreyev, A, Collins, PL, Tregoning, JS & Openshaw, PJM 2010, 'Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection', Journal of Virology, vol. 84, no. 10, pp. 5294-5302. https://doi.org/10.1128/JVI.02503-09
Harker, James A. ; Lee, Debbie C P ; Yamaguchi, Yuko ; Wang, Belinda ; Bukreyev, Alexander ; Collins, Peter L. ; Tregoning, John S. ; Openshaw, Peter J M. / Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection. In: Journal of Virology. 2010 ; Vol. 84, No. 10. pp. 5294-5302.
@article{587b997e3bf14c5eac2c6c1e79431d54,
title = "Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection",
abstract = "Respiratory syncytial virus (RSV) is the main cause of bronchiolitis, the major cause of hospitalization of infants. An ideal RSV vaccine would be effective for neonates, but the immune responses of infants differ markedly from those of adults, often showing a bias toward T-helper 2 (Th2) responses and reduced gamma interferon (IFN-γ) production. We previously developed recombinant RSV vectors expressing IFN-γ and interleukin-4 (IL-4) that allow us to explore the role of these key Th1 and Th2 cytokines during infection. The aim of the current study was to explore whether an immunomodulation of infant responses could enhance protection. The expression of IFN-γ by a recombinant RSV vector (RSV/IFN-γ) attenuated primary viral replication in newborn mice without affecting the development of specific antibody or T-cell responses. Upon challenge, RSV/IFN-γ mice were protected from the exacerbated disease observed for mice primed with wild-type RSV; however, antiviral immunity was not enhanced. Conversely, the expression of IL-4 by recombinant RSV did not affect virus replication in neonates but greatly enhanced Th2 immune responses upon challenge without affecting weight loss. These studies demonstrate that it is possible to manipulate infant immune responses by using cytokine-expressing recombinant viruses and that neonatal deficiency in IFN-γ responses may lead to enhanced disease during secondary infection.",
author = "Harker, {James A.} and Lee, {Debbie C P} and Yuko Yamaguchi and Belinda Wang and Alexander Bukreyev and Collins, {Peter L.} and Tregoning, {John S.} and Openshaw, {Peter J M}",
year = "2010",
month = "5",
doi = "10.1128/JVI.02503-09",
language = "English (US)",
volume = "84",
pages = "5294--5302",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection

AU - Harker, James A.

AU - Lee, Debbie C P

AU - Yamaguchi, Yuko

AU - Wang, Belinda

AU - Bukreyev, Alexander

AU - Collins, Peter L.

AU - Tregoning, John S.

AU - Openshaw, Peter J M

PY - 2010/5

Y1 - 2010/5

N2 - Respiratory syncytial virus (RSV) is the main cause of bronchiolitis, the major cause of hospitalization of infants. An ideal RSV vaccine would be effective for neonates, but the immune responses of infants differ markedly from those of adults, often showing a bias toward T-helper 2 (Th2) responses and reduced gamma interferon (IFN-γ) production. We previously developed recombinant RSV vectors expressing IFN-γ and interleukin-4 (IL-4) that allow us to explore the role of these key Th1 and Th2 cytokines during infection. The aim of the current study was to explore whether an immunomodulation of infant responses could enhance protection. The expression of IFN-γ by a recombinant RSV vector (RSV/IFN-γ) attenuated primary viral replication in newborn mice without affecting the development of specific antibody or T-cell responses. Upon challenge, RSV/IFN-γ mice were protected from the exacerbated disease observed for mice primed with wild-type RSV; however, antiviral immunity was not enhanced. Conversely, the expression of IL-4 by recombinant RSV did not affect virus replication in neonates but greatly enhanced Th2 immune responses upon challenge without affecting weight loss. These studies demonstrate that it is possible to manipulate infant immune responses by using cytokine-expressing recombinant viruses and that neonatal deficiency in IFN-γ responses may lead to enhanced disease during secondary infection.

AB - Respiratory syncytial virus (RSV) is the main cause of bronchiolitis, the major cause of hospitalization of infants. An ideal RSV vaccine would be effective for neonates, but the immune responses of infants differ markedly from those of adults, often showing a bias toward T-helper 2 (Th2) responses and reduced gamma interferon (IFN-γ) production. We previously developed recombinant RSV vectors expressing IFN-γ and interleukin-4 (IL-4) that allow us to explore the role of these key Th1 and Th2 cytokines during infection. The aim of the current study was to explore whether an immunomodulation of infant responses could enhance protection. The expression of IFN-γ by a recombinant RSV vector (RSV/IFN-γ) attenuated primary viral replication in newborn mice without affecting the development of specific antibody or T-cell responses. Upon challenge, RSV/IFN-γ mice were protected from the exacerbated disease observed for mice primed with wild-type RSV; however, antiviral immunity was not enhanced. Conversely, the expression of IL-4 by recombinant RSV did not affect virus replication in neonates but greatly enhanced Th2 immune responses upon challenge without affecting weight loss. These studies demonstrate that it is possible to manipulate infant immune responses by using cytokine-expressing recombinant viruses and that neonatal deficiency in IFN-γ responses may lead to enhanced disease during secondary infection.

UR - http://www.scopus.com/inward/record.url?scp=77951449856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951449856&partnerID=8YFLogxK

U2 - 10.1128/JVI.02503-09

DO - 10.1128/JVI.02503-09

M3 - Article

VL - 84

SP - 5294

EP - 5302

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 10

ER -